Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
algorithm
andexanet
anesthesia, epidural
anesthesia, spinal
antiarrhythmic drugs
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation effect
anticoagulation, perioperative
apixaban
argatroban
arrhythmia, cardiac
aspirin
asymptomatic
atrial appendage closure
atrial cardiopathy
atrial fibrillation
atrial fibrillation, nonvalvular
atrial fibrillation, risk stratification
atrial fibrillation, surgical treatment
atrial fibrillation, treatment
atrial flutter
atrial septal defect
bedridden
breast feeding
bridge therapy
bronchoscopy
cancer associated hypercoagulation
cancer, cerebrovascular accident complicating patients with
carcinoma
cardiomyopathy
carotid artery occlusion, intracranial
carotid artery occlusion, perioperative
CAT scan, abnormal
cataract surgery
cerebral embolism
cerebral embolism, cardiac origin
cerebral embolism, mechanical extraction
cerebral infarction
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, etiology
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, circadian rhythm
cerebrovascular accident, complications with
cerebrovascular accident, cryptogenic
cerebrovascular accident, nonarterial territory
cerebrovascular accident, postoperative
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, young adult
CHADS-VaSC score
children
ciraparantag
clopidogrel
clot retrieval
coagulopathy
colonoscopy
comorbidities
compliance
complications
controversies in neurology
cortical vein thrombosis
cost
cost effectiveness
coumarin
coumarin, restarting treatment
coumarin, stopping treatment
COVID-19
craniectomy, decompressive
cryoablation
dabigatran
dabigatran, dose
deafness, unilateral
delivery, complicated
dental extraction
dental procedure, neurologic complications with
dialysis
drug interactions
dural sinus thrombosis
dyspepsia
edoxaban
efficacy
electromyogram
embolic stroke of unknown source
embolism, systemic
endoscopic surgery
endoscopy
endovascular therapy
enoxaparin
evidence-based research
facial nerve palsy
factor Xa inhibitor
falling
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic therapy, selection criteria
gastrointestinal bleeding
gender
HAS-BLED score
head injury
headache
headache, thunderclap
heart valve, prosthetic
hematoma, epidural-spinal
hematomyelia
hemorrhagic diathesis
hemostatic therapy
heparin
heparin, low-molecular-weight
heparinoid, low molecular weight
hepatic failure
heprain induced thrombocytopenia
hip arthroplasty
Holter monitoring
hormone replacement
hormone therapy
hypercoagulable state
iatrogenic neurologic disorders
idarucizumab
incidental finding
INR value, time in range
INR values
intracerebral hemorrhage
intracerebral hemorrhage, progression of
intracerebral hemorrhage, silent
intracerebral hemorrhage, treatment of
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure, increased
labor, complicated
left atrial appendage, percutaneous closure
left ventricular dysfunction
liver disease
liver function enzymes
lumbar puncture
lumbar puncture, complications of
lymphoma
mastoiditis
menopause
MERCI trial
microhemorrhage, intracerebral
middle cerebral artery, occlusion of
mimics
misdiagnosis
mortality
MRI, abnormal
MRI, diffusion weighted
MRI, diffusion weighted, reversal
MRI, venography
myocardial infarction
neurologic complications of, surgery
neurologic disease, diagnoses of
neuroradiology, interventional
NIH stroke scale
non-vitamin K antagonist oral anticoagulants
non-vitamin K antagonist oral anticoagulants, coagulation test
number needed to treat
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
ovarian induction
pacemaker, cardiac-transvenous
partial thromboplastin time
patent foramen ovale, surgical treatment of
patient information and support
peri-procedural
platelet inhibiting drugs
platelet inhibiting drugs, combined
platelet inhibiting drugs, discontinuation
postoperative neurologic complications
practice guidelines
pregnancy, neurologic complications in
prethrombotic state
prevention of neurologic disorders
prognosis
prothrombin complex concentrate
prothrombin time
prothrombin time, prolonged
pulmonary embolism
radiofrequency ablation
rapid thromboelasticity
recanalization, arterial
recurrent
RELY trial
renal failure
reperfusion
RESPECT trial
review article
risk factors
risk factors, modification
risk stratification
risk-benefit assessment
rivaroxaban
ROCKET - AF trial
safety
seizure
seizure, focal
serum alanine aminotransferase
solitaire device
SPORTIF trial
stent, carotid artery
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
subdural hematoma
superior sagittal sinus thrombosis
T lesion of MCA-ICA
teratogenesis
teratogenic drugs
thrombectomy
thrombin inhibitor
thrombolysis, mechanical
thrombophlebitis
thrombophlebitis, prophylaxis
thrombus, mural
tissue plasminogen activator, intravenous
transient ischemic attack
transient neurologic deficit
transluminal angioplasty, coronary artery
transurethral prostatectomy
trauma
treatment of neurologic disorder
Trousseau's syndrome
vaccination, neurologic complications with
vaccine
vaccine-induced thrombocytopenia
venous thrombosis, non-cerebral
vitamin K
vitamin K antagonist
Watchman device
ximelagatran
Showing articles 600 to 650 of 1277 << Previous Next >>

Diagnosis of Cerebral Venous Thrombosis with Routine Magnetic Resonance: An Update
Eur Neurol 40:179-190, Bianchi,D.,et al, 1998

Preventing Stroke Recurrence in Patients with Patent Foramen Ovale: Antithrombotic Therapy, Foramen Closure, or Therapeutic Abstention? A Decision Analytic Perspective
Am Heart J 135:532-541, Nendaz,M.R.,et al, 1998

Does Daily Aspirin Diminish Severity of First-Ever Stroke
Arch Neurol 54:1369-1371, Karepov,V.,et al, 1997

Warfarin Use Among Patients with Atrial Fibrillation
Stroke 28:2382-2389, Brass,L.M.,et al, 1997

A Randomized Trial of Anticoagulants Vs Aspirin After Cerebral Ischemia of Presumed Arterial Origin
SPIRIT Study Group, Ann Neurol 42:857-8651997., , 1997

Local Thrombolytic Therapy in Deep Cerebral Venous Thrombosis
Neurol 48:1613-1619, Smith,A.G.,et al, 1997

Ischemic Stroke After Acute Myocardial Infarction
Stroke 28:762-767, Mooe,T.,et al, 1997

Ventricular Dysfunction and the Risk of Stroke After Myocardial Infarction
NEJM 336:251-257, Loh,E.,et al, 1997

Outcome of Aneurysmal Subarachnoid Hemorrhage in Patients on Anticoagulant Treatment
Stroke 28:6-9, Rinkel,G.E.J.,et al, 1997

Thromboembolism Prophylaxis in Chronic Atrial Fibrillation:Practice Patterns in Community & Tertiary-Care Hosp
Stroke 28:72-76, Munschauer,F.E.,et al, 1997

Clinical Characteristics & Mgt of Acute Stroke in Pts with Atrial Fib Admitted to US Univ Hosp
Neurol 48:1598-1604, Albers,G.W.,et al, 1997

Does Paroxysmal Atrial Fibrillation Confer a Paroxysmal Thromboembolic Risk
Lancet 349:1565-1566, Lip,G.Y.H., 1997

Ischemic Cerebral Infarction After rt-PA and Heparin Therapy for Acute Myocardial Infarction
Stroke 28:1107-1114, Sloan,M.A.,et al, 1997

CAST:Random Placebo-Controlled Trial of Early Aspirin Use in 20000 Pts with Acute Ischaemic Stroke
CAST Collab Grp, Lancet 349:1641-16491997., , 1997

Intl Stroke Trial:Random Trial of ASA
Subcut Heparin, Both, or Neither Among 19435 Pts with Ischaemic Stroke, IST Collab Grp, Lancet 349:1, 69-11997., 1997

Predictors of Hemorrhagic Transform Occurring Spont & On Anticoagulants in Pts with Acute Ischemic Stroke
Stroke 28:1198-1202, Alexandrov,A.V.,et al, 1997

Stroke Recurrence:Predictors, Severity, and Prognosis, The Copenhagen Stroke Study
Neurol 48:891-895, Jorgensen,H.S.,et al, 1997

Management of Anticoagulation Before and AFter Elective Surgery
NEJM 336:1506-1511, Kearon,C.&Hirsh,J., 1997

Ticlopidine and Thrombotic Thrombocytopenic Purpura
NEJM 337:1245, Kupfer,Y.&Tessler,S., 1997

Status of Antithrombotic Therapy for Patients with Atrial Firbrillation in University Hospitals
Arch Int Med 156:2311-2316, Albers,G.W.,et al, 1996

Percutaneous Transluminal Angioplasty of the Symptomatic Atherosclerotic Carotid Arteries
Stroke 27:2271-2273, Gil-Peralte,A.,et al, 1996

A Randomised
Blinded Trial of Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) , CAPRIE S, eerimte,Lancet 348:1329-1339,1996., 1996

Treatment of End Stage Dilated Cardiomyopathy
Br Heart J 72:S52-S56, O'Connell,J.B.,et al, 1996

Cerebellar Hemorrhagic Infarction
Neurol 46:346-349, Chaves,C.J.,et al, 1996

Hemorrhagic Transfor of Brain Infarct:Predictability in First 5 hrs. From Stroke Onset & Influ on Clin Outcome
Neurol 46:341-345, Toni,D.,et al, 1996

Spontaneous Spinal Epidural Hematoma:Findings at MR Imaging and Clinical Correlation
Radiology 199:409-413, Holtas,S.,et al, 1996

Prevalence of Risk Factors in Spontaneous Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage
Arch Neurol 53:734-740, Juvela,S., 1996

Aspirin in Ischemic Cerebrovascular Disease-How Strong is the Case for a Different Dosing Regimen
Stroke 27:756-760, Patrono,C.&Roth,G.J., 1996

Aspirin Wars-The Optimal Dose of Aspirin to Prevent Stroke
Stroke 27:585-587, Hart,R.G.&Harrison,M.J.G., 1996

Aspirin Dose in Stroke Prevention-Beautiful Hypotheses Slain by Ugly Facts
Stroke 27:588-592, Barnett,H.J.M.,et al, 1996

Bleeding During Antithrombotic Therapy in Patients with Atrial Fibrillation
Stroke Prevention in Atrial Fib Invest, Arch Int Med 156:409-4161996., , 1996

Differential Effect of Aspirin Vs Warfarin on Clinical Stroke Types in Pts with Atrial Fibrillation
Neurol 46:238-240, Miller,V.T.,et al, 1996

Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996

Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 22-1996, NEJM 335:189-196996., , 1996

The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
Ann Int Med 124:970-979, Fihn,S.D.,et al, 1996

US Nat'l Survey of Phy Pract for 2nd & Tertiary Prevent of Ischemic Stroke, Med Therapy in Carotid Art Stenosis
Stroke 27:1473-1478, Goldstein,L.B.,et al, 1996

An Analysis of Lowest Effective Intensity of Prophylactic Anticoagulation for Pts with Nonrheumatic Atrial Fib
NEJM 335:540-546, 5871996., Hylek,E.M.,et al, 1996

Spontaneous Bilateral Subdural Hematomas Associated with Chronic Ginkgo Biloba Ingestion
Neurol 46:1775-1776, Rowin,J.&Lewis,S., 1996

Adjusted-Dose Warfarin Vs Low-Intens
Fixed-Dose Warfarin+Aspirin for High-Risk Pts with Atrial Fib, SPAFIII Invest, Lancet 348:633-638996, , 1996

Accuracy of Transesophageal Echocardiography for Ident Left Atrial Thrombi:Prospective, Intraop Study
Ann Int Med 123:817-822, 8821995., Manning,W.J.,et al, 1995

Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation
JAMA 274:1839-1845, Gage,B.F.,et al, 1995

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
NEJM 332:993-997, 10251995., Khamashta,M.A.,et al, 1995

Optimal Oral Anticoag Therapy in Pts with Nonrheumatic Atrial Fib & Recent Cerebral Ischemia
European Atrial Fib Study Group, NEJM 333:5-10, 54995., , 1995

Surgical Management of Spinal Epidural Hematoma:Relationship Between Surgical Timing and Neurological Outcome
J Neurosurg 83:1-7, Lawton,M.T.,et al, 1995

Lack of Effect of Aspirin in Asymptomatic Patients with Carotid Bruits and Substantial Carotid Narrowing
Ann Int Med 123:649-655, Cote,R.,et al, 1995

A 79-Year Old Musician with Asymptomatic Carotid Artery Disease
JAMA 274:1383-1389, Caplan,L.R., 1995

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke
NEJM 333:1588-1593, Kay,R.,et al, 1995

Physician Attitudes About Anticoagulation for Nonvalvular Atrial Fibrillation in the Elderly
Arch Int Med 155:277-281, McCrory,D.C.,et al, 1995

Sneddon's Syndrome is a Thrombotic Vasculopathy:Neuropathologic and Neuroradiologic Evidence
Neurol 45:557-560, Geschwind,D.H.,et al, 1995

Stroke Prevention Therapies and Management of Patient Subgroups
Neurol 45:S19-S24, Raps,E.C.&Galetta,S.L., 1995



Showing articles 600 to 650 of 1277 << Previous Next >>